Cabaletta Bio Stock Probability of Future Stock Price Finishing Under 0.07

CABA Stock  USD 12.96  0.36  2.70%   
Cabaletta Bio's implied volatility is one of the determining factors in the pricing options written on Cabaletta Bio. Implied volatility approximates the future value of Cabaletta Bio based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Cabaletta Bio over a specific time period. For example, 2024-05-17 CALL at $12.5 is a CALL option contract on Cabaletta Bio's common stock with a strick price of 12.5 expiring on 2024-05-17. The contract was last traded on 2024-04-23 at 12:49:36 for $2.04 and, as of today, has 23 days remaining before the expiration. The option is currently trading at a bid price of $1.1, and an ask price of $1.95. The implied volatility as of the 25th of April is 80.56. View All Cabaletta options

Closest to current price Cabaletta long CALL Option Payoff at Expiration

Cabaletta Bio's future price is the expected price of Cabaletta Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cabaletta Bio performance during a given time horizon utilizing its historical volatility. Check out Cabaletta Bio Backtesting, Cabaletta Bio Valuation, Cabaletta Bio Correlation, Cabaletta Bio Hype Analysis, Cabaletta Bio Volatility, Cabaletta Bio History as well as Cabaletta Bio Performance.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
  
At present, Cabaletta Bio's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 1.91, whereas Price Earnings Ratio is forecasted to decline to (14.42). Please specify Cabaletta Bio's target price for which you would like Cabaletta Bio odds to be computed.

Cabaletta Bio Target Price Odds to finish below 0.07

The tendency of Cabaletta Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.07  or more in 90 days
 12.96 90 days 0.07 
near 1
Based on a normal probability distribution, the odds of Cabaletta Bio to drop to $ 0.07  or more in 90 days from now is near 1 (This Cabaletta Bio probability density function shows the probability of Cabaletta Stock to fall within a particular range of prices over 90 days) . Probability of Cabaletta Bio price to stay between $ 0.07  and its current price of $12.96 at the end of the 90-day period is about 1.03 .
Given the investment horizon of 90 days Cabaletta Bio has a beta of 0.3 suggesting as returns on the market go up, Cabaletta Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cabaletta Bio will be expected to be much smaller as well. Additionally Cabaletta Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Cabaletta Bio Price Density   
       Price  

Predictive Modules for Cabaletta Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cabaletta Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cabaletta Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
9.2413.1417.04
Details
Intrinsic
Valuation
LowRealHigh
12.0115.9119.81
Details
Naive
Forecast
LowNextHigh
6.2810.1814.08
Details
11 Analysts
Consensus
LowTargetHigh
23.0125.2928.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cabaletta Bio. Your research has to be compared to or analyzed against Cabaletta Bio's peers to derive any actionable benefits. When done correctly, Cabaletta Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cabaletta Bio.

Cabaletta Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cabaletta Bio is not an exception. The market had few large corrections towards the Cabaletta Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cabaletta Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cabaletta Bio within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.6
β
Beta against NYSE Composite0.30
σ
Overall volatility
3.08
Ir
Information ratio -0.16

Cabaletta Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cabaletta Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cabaletta Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cabaletta Bio generated a negative expected return over the last 90 days
Cabaletta Bio has high historical volatility and very poor performance
Net Loss for the year was (67.67 M) with profit before overhead, payroll, taxes, and interest of 0.
Cabaletta Bio currently holds about 96.81 M in cash with (53.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34.
Cabaletta Bio has a poor financial position based on the latest SEC disclosures
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Acquisition by Henriques Richard C Jr of 22000 shares of Cabaletta Bio subject to Rule 16b-3

Cabaletta Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cabaletta Stock often depends not only on the future outlook of the current and potential Cabaletta Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cabaletta Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding40.9 M
Cash And Short Term Investments241.2 M

Cabaletta Bio Technical Analysis

Cabaletta Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Cabaletta Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cabaletta Bio. In general, you should focus on analyzing Cabaletta Stock price patterns and their correlations with different microeconomic environments and drivers.

Cabaletta Bio Predictive Forecast Models

Cabaletta Bio's time-series forecasting models is one of many Cabaletta Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cabaletta Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Cabaletta Bio

Checking the ongoing alerts about Cabaletta Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cabaletta Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cabaletta Bio generated a negative expected return over the last 90 days
Cabaletta Bio has high historical volatility and very poor performance
Net Loss for the year was (67.67 M) with profit before overhead, payroll, taxes, and interest of 0.
Cabaletta Bio currently holds about 96.81 M in cash with (53.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34.
Cabaletta Bio has a poor financial position based on the latest SEC disclosures
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Acquisition by Henriques Richard C Jr of 22000 shares of Cabaletta Bio subject to Rule 16b-3
When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:
Check out Cabaletta Bio Backtesting, Cabaletta Bio Valuation, Cabaletta Bio Correlation, Cabaletta Bio Hype Analysis, Cabaletta Bio Volatility, Cabaletta Bio History as well as Cabaletta Bio Performance.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
Note that the Cabaletta Bio information on this page should be used as a complementary analysis to other Cabaletta Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Cabaletta Stock analysis

When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stocks Directory
Find actively traded stocks across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is Cabaletta Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.65)
Return On Assets
(0.25)
Return On Equity
(0.40)
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.